CONSHOHOCKEN, Pa., Feb. 28, 2025 /PRNewswire/ -- The GBS | CIDP Foundation International today released new survey data illustrating how people with Guillain-Barré Syndrome experience this life ...

Researchers are working overtime to develop therapies that, for the first time, specifically target Guillain-Barré Syndrome.

In lieu of flowers, please consider a donation to the GBS/CIDP Foundation International or to Penn State St. Joseph Medical Center. Online condolences can be made at maestumpfuneralhome.com ...

In lieu of flowers, donations may be made to the Guillain-Barre Syndrome at the GBS/CIDP Foundation International, 375 East Elm Street, Suite 101, Conshohocken, PA 19428. May his memory be a blessing.

CONSHOHOCKEN, PA — The GBS | CIDP Foundation International has unveiled survey data that paints a sobering picture of the physical, social, and financial challenges faced by individuals with ...

The life-altering consequences of GBS were recently detailed in a new patient survey released by the GBS/CIDP Foundation that underscores the significant unmet need notwithstanding standard of ...

These accomplishments have laid a robust foundation for our continued momentum ... a key driver of this growth in 2025 for both MG and CIDP. It is incredible to see the strong early adoption ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...